Milk Exomes LL oral delivery: Scroll to: B. S
Post# of 148109
(Total Views: 443)
Posted On: 08/15/2024 1:02:38 AM
Milk Exomes LL oral delivery:
Scroll to:
B. Source of Milk Vesicles
Scroll to:
Table 8 below provides exemplary anti-inflammatory agents that can be used, either alone or in combination with an anti-infection agent, in treatment of an infection.
Such agents also can be loaded into LNP-MPVs for oral delivery.
Excerpt from that section:
"Minimize a dysregulated inflammatory response and cytokine storm in patients with acute infection CYDY , NIH of Mexico PRO 140 (leronlimab) CCR5 antagonist"
___________
Look @ one of the Authors of the patent, Bhushan Pattni, LinkedIn excerpt under PureTech on this milk exomes patent program, although he left in 2021:
"Discuss, develop and present milestones for the lead products within the company and with its multi-national collaborators and strategic partners (Roche)"
https://www.linkedin.com/in/bhushan-pattni-phd-52733b17
Author Joseph Bolen is @ PureTech.
___________
Does Roche own the drug mentioned by Cytodyn, in Monday's news ? Think that's what someone posted.
1st study I have seen stating Leronlimab can be given orally. Sending patent link to Cytodyn info.
If they are already aware &/or looking into this...then.
Don't want to get to excited, but....wow the potential this would be, even if for only certain situations.
Scroll to:
B. Source of Milk Vesicles
Scroll to:
Table 8 below provides exemplary anti-inflammatory agents that can be used, either alone or in combination with an anti-infection agent, in treatment of an infection.
Such agents also can be loaded into LNP-MPVs for oral delivery.
Excerpt from that section:
"Minimize a dysregulated inflammatory response and cytokine storm in patients with acute infection CYDY , NIH of Mexico PRO 140 (leronlimab) CCR5 antagonist"
___________
Look @ one of the Authors of the patent, Bhushan Pattni, LinkedIn excerpt under PureTech on this milk exomes patent program, although he left in 2021:
"Discuss, develop and present milestones for the lead products within the company and with its multi-national collaborators and strategic partners (Roche)"
https://www.linkedin.com/in/bhushan-pattni-phd-52733b17
Author Joseph Bolen is @ PureTech.
___________
Does Roche own the drug mentioned by Cytodyn, in Monday's news ? Think that's what someone posted.
1st study I have seen stating Leronlimab can be given orally. Sending patent link to Cytodyn info.
If they are already aware &/or looking into this...then.
Don't want to get to excited, but....wow the potential this would be, even if for only certain situations.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼